These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 606443)

  • 21. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
    J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytes.
    Mold C; Medof ME
    Mol Immunol; 1985 May; 22(5):507-12. PubMed ID: 3848661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of factor B of the complement system by kallikrein and its light chain.
    Hiemstra PS; Daha MR; Bouma BN
    Thromb Res; 1985 Jun; 38(5):491-503. PubMed ID: 3848216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reexamination of the role of magnesium in the human alternative pathway of complement.
    Pryzdial EL; Isenman DE
    Mol Immunol; 1986 Jan; 23(1):87-96. PubMed ID: 3634188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba.
    Ueda A; Kearney JF; Roux KH; Volanakis JE
    J Immunol; 1987 Feb; 138(4):1143-9. PubMed ID: 2433342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):497-504. PubMed ID: 6918218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.
    Kossorotow A; Opitz W; Etschenberg E; Hadding U
    Biochem J; 1977 Nov; 167(2):377-82. PubMed ID: 597250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes.
    Rother U
    J Immunol Methods; 1982; 51(1):101-7. PubMed ID: 6921216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b.
    Maillet F; Kazatchkine MD; Glotz D; Fischer E; Rowe M
    Mol Immunol; 1983 Dec; 20(12):1401-4. PubMed ID: 6558419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of classical C5 convertase in the complement system by factor H.
    Ito S; Tamura N
    Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of the amplification convertase of complement by monoclonal antibodies directed against human factor B.
    Daha MR; Deelder AM; Van Es LA
    J Immunol; 1984 May; 132(5):2538-42. PubMed ID: 6232321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proteolytic activation systems of complement.
    Reid KB; Porter RR
    Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.
    Jouvin MH; Kazatchkine MD; Cahour A; Bernard N
    J Immunol; 1984 Dec; 133(6):3250-4. PubMed ID: 6238095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.